Karmanos Cancer Institute was awarded the President’s Trophy for second year in a row by McLaren Health Care
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…
Karmanos Cancer Institute received the 2020 Women’s Choice Award
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
The FDA approved new treatment option for patients with HER2-positive breast cancer
On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…
The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancer
On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…
The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its…
Karmanos Cancer Institute established the McLaren Proton Therapy Center
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos, Wayne State received $3.1 million NIH grant to improve quality of life for African American cancer survivors
On Sept. 24, 2019 Karmanos, Wayne State announced it had received a $3.1 million National Institutes of Health…
Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatment
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery system
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancer
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
Biotechnology | Disease | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Therapeutics
CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
Siteman Cancer Center awarded $7.8 million to expand clinical trials access
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
Columbia Sportswear’s Tim and Mary Boyle announced a $10 million gift to OHSU Knight Cancer Institute
On Jun. 18, 2019, Columbia Sportswear President and CEO Tim Boyle and his wife, Mary, announced a donation…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Vaccine
Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird Bioscience
On Jun. 4, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $13 million relocation…
Amgen announced the launch of Amgen Community Oncology Research Collaborators
On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
Karmanos Cancer Institute awarded President’s Trophy by McLaren Health Care system
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
Researchers discovered way to kill dormant, hiding breast cancer cells, an avenue for preventing relapse
On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…
Karmanos Cancer Institute and Wayne State University awarded prestigious LAPS grant
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
Karmanos Morey Cancer Center recognized by the American Society of Clinical Oncology with the QOPI Certification Program
On Dec. 17, 2018, the Karmanos Morey Cancer Center was recognized by the American Society of Clinical Oncology…
Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
Siteman Cancer Center to offer newest form of proton therapy
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
The Cancer Prevention and Research Institute announced the formation of the 2018 Texas Cancer Plan
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics | Women's Health
The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
UCSD researchers discovered that a type of DNA-repairing enzyme is neutralized by DNA lesions caused by exposure to ultraviolet light
On Aug. 22, 2018, University of California, San Diego (UCSD) researchers with colleagues in Spain and Finland, described…